FDA Announces Draft Guidance for Electronic Submission of Biologics and Drug Applications

Summary

The US Food and Drug Administration (FDA) has released a draft document outlining the standardized format for electronic submission of marketing applications content for biologics and drug inspections by the Center for Biologics Evaluation and Research (CBER) and the Office of Regulatory Affairs (ORA).